GridAI Technologies Corp. (GRDX) Stock

NASDAQ: GRDXHealthcare company in the biotechnology industry, based in Edinburgh, USA.

GridAI Technologies stock price chart

GRDX interactive chart →

GRDX stock quote & key statistics

GridAI Technologies earnings per share

Income →
Earnings per share

GridAI Technologies revenue & net income

Income →
RevenueNet income

GridAI Technologies annual financials

Income statement →
Fiscal yearRevenueNet incomeEPS
FY2025$36,251-$6.4M-$2.17
FY2024$0-$18.1M-$18.63
FY2023$0-$15.8M-$258.22
FY2022$0-$14.6M-$11.11
FY2021$0-$58.5M-$6.54

Fiscal year ending December 31. Source: company filings via EODHD.

About GridAI Technologies Corp.

GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in Edinburgh, United Kingdom.

GridAI Technologies stock FAQ

What is the GridAI Technologies stock ticker symbol?

GridAI Technologies Corp. trades on the NASDAQ under the ticker symbol GRDX.

What sector and industry is GridAI Technologies in?

GridAI Technologies Corp. is classified in the Healthcare sector, Biotechnology industry.

What were GridAI Technologies's revenue and earnings last fiscal year?

GridAI Technologies reported revenue of $36,251 and net income of -$6.4M in fiscal 2025, with earnings per share of -$2.17.

When did GridAI Technologies go public?

GridAI Technologies stock began trading on October 11, 2016.

Biotechnology stocks

All Healthcare stocks →